US biotech firm wants to test its pneumonia treatment in COVID-19 patients

BioAegis of New Jersey is developing a drug using gelsolin, a protein that helps to clear away inflammation from pneumonia, which is responsible for the deaths of coronavirus patients.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news